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1 |  INTRODUCTION
Events such as pneumonia, inhalational injury, trauma, or 
sepsis can damage the lung, which consequently impedes 
its primary function of gas exchange. These events can re-
sult in acute respiratory distress syndrome (ARDS), a clin-
ical syndrome that has significant morbidity and mortality 
in the United States each year (Phua et al., 2009; Thompson, 
Chambers, & Liu, 2017). The most common risk factors for 
ARDS are pneumonia or sepsis (Tsushima et al., 2009).
The mechanisms underlying the pathogenesis of ARDS 
have been significantly advanced in recent years, and the 
immunologic responses that occur early in ARDS elicit 
immune-mediated alveolar damage (Huang et al., 2005; 
DOI: 10.14814/phy2.14368  
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Abstract
The immunologic responses that occur early in the acute respiratory distress syn-
drome (ARDS) elicit immune-mediated damage. The mechanisms underlying the 
resolution of ARDS, particularly the role of signaling molecules in regulating im-
mune cell kinetics, remain important questions. Th1-mediated responses can con-
tribute to the pathogenesis of acute lung injury (ALI). Interferon-gamma (IFN-γ) 
orchestrates early inflammatory events, enhancing immune-mediated damage. The 
current study investigated IFN-γ during resolution in several experimental models 
of ALI. The absence of IFN-γ resulted in altered kinetics of lymphocyte and mac-
rophage responses, suggesting that IFN-γ present in this microenvironment is influ-
ential in ALI resolution. Genetic deficiency of IFN-γ or administering neutralizing 
IFN-γ antibodies accelerated the pace of resolution. Neutralizing IFN-γ decreased 
the numbers of interstitial and inflammatory macrophages and increased alveolar 
macrophage numbers during resolution. Our results underline the complexity of lung 
injury resolution and provide insight into the effects through which altered IFN-γ 
concentrations affect immune cell kinetics and the rate of resolution. These find-
ings suggest that therapies that spatially or temporally control IFN-γ signaling may 
promote ALI resolution. Identifying and elucidating the mechanisms critical to ALI 
resolution will allow the development of therapeutic approaches to minimize collat-
eral tissue damage without adversely altering the response to injury.
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Ramana et al., 2015; Theron, Huang, Chen, Liu, & Lei, 
2005; Wlodarczyk, Kraft, Chen, Kenney, & Selin, 2013). 
Th1-mediated responses can contribute to the pathogenesis 
of acute lung injury (ALI) (Aggarwal, King, & D'Alessio, 
2014). A critical Th1 mediator, interferon-gamma (IFN-
γ), enhances inflammatory and immune-mediated damage 
(Clark et al., 1998; Rijneveld et al., 2002; Schultz, Rijneveld, 
Speelman, Deventer, & Poll, 2001; Theron et al., 2005).
After an acute injury, repair and the resolution of the 
damage must occur for adequate gas exchange to return. 
Resolution from injury is not merely relief from injurious 
stimuli, but rather an actively regulated program involving 
removal of apoptotic neutrophils, remodeling of the matrix, 
reabsorption of protein-rich alveolar fluid, and repair of the 
endothelial and epithelial cells of the alveolar space (Huynh, 
Fadok, & Henson, 2002; Kieran, Maderna, & Godson, 2004; 
Savill, 1997; Serhan & Savill, 2005). Less is known about 
what effects immunologic signaling molecules, such as IFN-
γ, have on immune cell kinetics during resolution of ALI.
IFN-γ is a type II IFN and the sole member of this fam-
ily. A broad range of cells produce IFN-γ, and significant 
contributing populations include CD4+ T helper type I 
lymphocytes, CD8+ cytotoxic lymphocytes, group 1 innate 
lymphoid cells (ILC1s) and NK cells, as well as antigen-pre-
senting cells, B lymphocytes, neutrophils, and NK T lympho-
cytes (Fenimore, 2016; Riggan, Freud, & O'Sullivan, 2019; 
Varma, Lin, Toliver-Kinsky, & Sherwood, 2002). IFN-γ 
production by neutrophils occurs during Streptococcus pneu-
moniae pneumonia (Gomez et al., 2015). Cytokines such as 
IL-12 and IL-18 are upstream signals for IFN-γ production, 
whereas negative regulators of IFN-γ expression include 
glucocorticoids, IL-4, IL-10, and TGFβ (Fenimore, 2016). 
IFN-γ is vital for host immunity against intracellular patho-
gens, whereas its role in host defense toward extracellular 
pathogens is more variable (Moldoveanu et al., 2009).
The receptor for IFN-γ is comprised of two IFNGR1 chains 
and two IFNGR2 chains. IFNGR1 is expressed on most cells 
at moderate levels, while IFNGR2 is expressed at lower lev-
els; however, IFNGR2 expression can be regulated in spe-
cific cell types (Bach, Aguet, & Schreiber, 1997; Bernabei et 
al., 2001; Fenimore, 2016; Green, Young, & Valencia, 2017; 
Londino et al., 2017). Ifng−/− and Ifngr1−/− mice develop 
normally and have a typical immune system, but both gen-
otypes have defects in resistance to some infectious agents, 
including mycobacterial species, some viruses, and bacte-
ria; conversely, the Ifngr1−/− mice are more resistant to LPS 
(Car et al., 1994; Nakamura et al., 2000; Schroder, Hertzog, 
Ravasi, & Hume, 2004).
In this study, we sought to determine the changes in the 
development and resolution of ALI that result from the defi-
ciency of IFN-γ. Our studies focused on LPS-induced ALI, 
examining both day 4 and day 7. Day 4 post-injury is the time 
of peak inflammation when the numbers of neutrophils and 
inflammatory macrophages are peaking. By day 7 post-in-
jury, resolution is underway; type II epithelial cell (AT2) pro-
liferation is high, lymphocyte numbers are increasing, and 
neutrophils and inflammatory macrophages are decreased. 
Two other stimuli that are important common causes of lung 
injury (S. pneumoniae and H1N1 influenza) were also stud-
ied to identify and compare the effects of IFN-γ deficiency 
at a time point during resolution when mice have regained 
much of their weight loss (Arpaia et al., 2015; Gomez et al., 
2017; Matute-Bello, Frevert, & Martin, 2008). These studies 
identified the contribution of IFN-γ both to lung injury and 
to changes in immune cell kinetics during resolution from 
lung injury.
2 |  METHODS
2.1 | Mice
C57BL/6 wild-type (WT) and Ifng−/− mice were obtained 
from Jackson Laboratory (Dalton et al., 1993). Mice were 
housed in ventilated cages, and colonies were maintained 
within a pathogen-free facility at the University of North 
Carolina at Chapel Hill. Animal procedures and protocols 
were approved by the University of North Carolina Animal 
Care and Use Committee.
2.2 | Preparation of Mice for LPS 
administration
Eight to twelve-week-old male and female mice were anes-
thetized and administered lipopolysaccharide, Escherichia 
coli LPS O55:B5 (3 mg/kg) (Sigma-Aldrich), as previously 
described (D'Alessio et al., 2009; Dial, Tune, Doerschuk, & 
Mock, 2017; Mock et al., 2014).
2.3 | Bacterial pneumonia
Streptococcus pneumoniae (S.  pneumoniae; serotype 19, 
ATCC 49619) was purchased from American Type Culture 
Collection. Bacteria were grown overnight at 37°C in 5% 
CO2 on blood agar plates, 5% sheep blood in tryptic soy agar 
(ThermoFisher). 10–20 colonies were then suspended in 
Todd-Hewitt Broth (Becton Dickinson) supplemented with 
17% (v/v) Fetal Bovine Serum (ThermoFisher) and incubated 
at 37°C with shaking at 225 rpm for several hours until an 
OD600 0.3 was reached as previously described (D'Alessio, 
2018). The media was distributed into 1 ml aliquots and flash-
frozen in liquid nitrogen before storage at −80°C (D'Alessio, 
2018). Pneumonia was induced by intratracheal instillation 
of the thawed bacterial suspension at a dose of 2 µl/g mouse 
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body weight. Colony-forming units (CFU) in bacterial sus-
pensions were subsequently determined by plating serial di-
lutions of the bacterial suspension on blood agar plates. The 
range of CFUs was 4.79–7.54 × 106 CFU/mouse.
2.4 | Influenza infection
Influenza A/PR/8/34 H1N1 (PR8) was purchased from 
Charles River (Norwich, CT; Catalog # 10100374). The viral 
administration has been dose-optimized for eliciting a robust 
inflammatory response and modest mortality of 10 to 15 per-
cent, facilitating a better study of the resolution phase of ALI 
(Kanegai et al., 2016; Mock et al., 2014). The virus was sus-
pended and diluted in PBS and stored at −80°C at 2 × 108 
egg-infective dose/ml (EID). Pneumonia was induced by in-
tratracheal instillation of the thawed viral suspension diluted 
in PBS to 5 × 105 EID/ml. Mice received 40 μl of this dilu-
tion intratracheally.
2.5 | RNA isolation and analysis of 
Influenza A M2 gene expression
At time points after influenza A infections, lungs were snap-
frozen in liquid nitrogen and RNA obtained to quantitate viral 
expression as previously described (Hagan, Torres-Castillo, 
& Doerschuk, 2019).
2.6 | In vivo antibody-mediated 
neutralization of IFN- γ
WT animals were given 20 µg/dose/mouse of intraperitoneal 
injections of a rat monoclonal anti- IFN-γ antibody (Clone 
AN-18) or isotype control (IgG1 κ isotype, BioLegend) on 
days 1, 2, and 3 post LPS administration. See Table S1 for 
clone and catalog numbers.
2.7 | Analysis of BAL fluid
BAL was performed by cannulating the trachea with a 20-
gauge catheter and lavaging the lungs with PBS as previously 
described (D'Alessio et al., 2009; Mock et al., 2014).
2.8 | Lung morphology
Lungs were inflated to 25  cm H2O and fixed with 10% 
formalin (ThermoFisher) for histological evaluation by he-
matoxylin and eosin staining (D'Alessio et al., 2009; Mock 
et al., 2019).
2.9 | Preparation of lung single-cell 
suspensions for flow cytometry analysis
At endpoints, uninjured, baseline (control), 4, 6, 7, or 15 days 
after instillation, mice were euthanized by isoflurane over-
dose as previously described (Dial et al., 2017). Lungs were 
removed, and single-cell suspensions were prepared for flow 
cytometry analysis as described previously (Dial et al., 2017; 
Mock et al., 2019). See Table S1 for clone and catalog num-
bers. The neutrophils and macrophage subpopulations were 
identified through gating, as demonstrated in Figure S2 and 
adapted from (Misharin, Morales-Nebreda, Mutlu, Budinger, 
& Perlman, 2013), and these four populations were immu-
nophenotyped as:
1. Neutrophils: CD45+CD64+CD24+CD11b+SiglecF-Ly6G+
2. Alveolar macrophages: CD45+CD64+CD11c+MHCII±Si
glecF+Ly6C-
3. Interstitial macrophages: CD45+CD64+CD11b+MHCII+ 
SiglecF-Ly6G-Ly6C-
4. Inflammatory macrophage: CD45+CD64+CD11b+MHCII+ 
SiglecF-Ly6G-Ly6C+.
2.10 | Statistics
Analysis of data utilized comparisons using the Mann–
Whitney rank-sum test or one-way or two-way ANOVA with 
Tukey's or Holm–Sidak methods for multiple t-test compari-
sons. Data are expressed as the mean ± standard error of the 
mean. Statistical analysis was performed using GraphPad 
Prism 7 software. Statistical difference was accepted at 
p < .05.
3 |  RESULTS
3.1 | The effects of IFN-γ on immune cell 
kinetics during ALI induced by LPS
In naïve (uninjured) mice, there were no differences in the 
numbers of any immune cell types examined between Ifng−/− 
and WT mice in either the BAL or the lung digest (Figure 1 
and Figure S1). Mice lacking IFN-γ during LPS-induced ALI 
had significantly less weight loss compared to control mice 
(Figure 1a). No difference in mortality occurred between 
genotypes (Figure S1a). Lung histopathology at day 4 dem-
onstrated less cellularity in the Ifng−/− mice compared to WT 
(Figure S1b). The BAL cell count and total protein at time 
points of peak injury (Day 4) and during resolving lung in-
jury (Day 7) were similar between genotypes (Figure 1b and 
c). Interestingly, in the BAL compartment at day 4 post LPS, 
a time point of peak inflammation, Ifng−/− mice contained 
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more CD4+ and Treg cells than WT mice; however, by day 
7, the numbers of these lymphocytes were similar between 
genotypes (Figure 1d–f).
The lungs of Ifng−/− mice had less cellularity than WT 
mice, as demonstrated by the total number of cells obtained 
from lung digests at 4 days post LPS; however, no differences 
were present between genotypes by day 7 (Figure 1g). In these 
lung digests, Ifng−/− mice had more alveolar macrophages 
on Day 4 and 7 post LPS (Figure 1h, please see Methods 
section for a complete definition of cell populations). Ifng−/− 
mice had fewer neutrophils at day 4, and fewer interstitial 
and inflammatory macrophages on both days 4 and 7 post 
LPS (Figure 1i–k); representative gating is shown in Figure 
S2 (adapted from (Misharin et al., 2013)). In the BAL com-
partment, Ifng−/− mice also had more alveolar macrophages 
on Day 7 post LPS and fewer neutrophils and interstitial and 
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inflammatory macrophages (data not shown). Interestingly, 
the increase in inflammatory macrophages, which are re-
cruited from the bone marrow, was entirely prevented by the 
absence of IFN-γ.
In the same lung digests, Ifng−/− lungs contained fewer 
CD8+ lymphocytes at day 4 and 7 post LPS, and fewer CD3+ 
and CD4+ lymphocytes on day 7 (Figure 1l–n), as identi-
fied by flow cytometry with gating as previously reported 
(Mock et al., 2019). There was no significant difference in 
the number of lung Foxp3+ Tregs between genotypes, and 
Tregs increased in both genotypes on day 7 during reso-
lution (Figure 1o). The number of γδ+ lymphocytes was 
lower at day 7 post LPS in Ifng−/− mice (Figure 1p). No 
significant difference was detected in CD19+ lymphocytes 
or NK T lymphocytes on either day 4 or 7 post-injury be-
tween genotypes (Figure 1q and r). The number of NK cells 
was lower on day 4 (Figure 1s). The increases in CD4+ and 
CD8+ lymphocytes were entirely prevented by the absence 
of IFN-γ, while the increases in γδ+ lymphocytes and NK 
cells appear only partially due to IFN-γ. In BAL fluid at 
day 7, only γδ+ lymphocytes and CD19+ cells were signifi-
cantly different between genotypes and present in higher 
numbers in Ifng−/− mice (data not shown).
The percentage of CD4+ lymphocytes that were ac-
tivated or effector CD4+ cells, as determined by CD44+ 
CD62Llo surface marker expression, was lower only at day 
7 in Ifng−/− mice when compared to WT (Figure S1c–f). 
The percentage of effector CD8+ lymphocytes was similar 
in both genotypes at all time points examined. The percent-
age of lung CD4+ lymphocytes that co-expressed Foxp3 
(percentage of total CD4+ cells that were Foxp3+) did not 
differ between genotypes but did increase at 7  days post 
LPS (Figure S1g).
Interestingly, when the numbers and percentages of 
proliferating endothelial (CD31+) and epithelial (CD326+) 
cells were examined, Ifng−/− mice had increased total num-
bers of both CD31+ and CD326+ cells at day 7 post-injury 
compared to WT mice (Figure S1h and k). The percentage 
and number of proliferating epithelial cells did not differ 
between genotypes; however, on day 4, the percentage and 
number of proliferating endothelial cells were higher in 
Ifng−/− mice compared to WT (Figure S1h–m). Curiously, 
both the percentage and the number of proliferating endo-
thelial cells were higher in WT mice by Day 7, but this 
increase in proliferation and number occurred earlier in 
Ifng−/− mice by day 4 (Figure S1l and m). Taken together, 
this suggests that IFN-γ has different effects on individual 
cell types.
3.2 | The effects of IFN-γ on immune cell 
kinetics during ALI induced by S. pneumoniae
Mice given ALI induced by Streptococcus pneumoniae 
(Sp) were studied 6 days after infection, a time point dur-
ing resolution when infected mice have regained much of 
their weight loss (Gomez et al., 2017; Matute-Bello et al., 
2008) Mice lacking IFN-γ had a similar weight loss and 
return to baseline weight by 6 days post-Sp, compared to 
WT mice (Figure 2a). In prior reports, similar inocula of Sp 
did not demonstrate a difference in bacterial clearance be-
tween genotypes (Yamada et al., 2011). There was no dif-
ference in survival between genotypes (Figure S3a). Lung 
histopathology at day 6 appeared similar between geno-
types (Figure S3b). Ifng−/− mice had a lower total BAL 
cell count and total protein concentration than WT mice 
(Figure 2b and c). When comparing myeloid and lymphoid 
cell numbers in the BAL compartment, only inflammatory 
macrophages were significantly different between geno-
types and present in lower numbers in Ifng−/− mice (data 
not shown).
The lungs of Ifng−/− mice had similar cellularity, as 
demonstrated by the total number of cells obtained from 
lung digests at 6 days post-Sp (Figure 2d). In lung digests, 
Ifng−/− mice had fewer lung interstitial and inflammatory 
macrophages and more alveolar macrophages than WT mice 
(Figure 2e, Figure S2). In the same lung digests, Ifng−/− lungs 
contained fewer NK cells at day 6 and more γδ+ lymphocytes 
F I G U R E  1  Interferon-γ null mice have altered ALI immune cell populations and resolution kinetic parameters. Ifng−/− or WT mice were 
challenged with intratracheal LPS administered on day 0. Uninjured mice or mice after injury were examined at day 4 or 7 post LPS for injury 
parameters or immunophenotyping in the BAL compartment or enzymatic single-cell lung suspensions. (a) Body weight relative to baseline 
determined after injury (n = 38–49 per group for Ifng−/− mice; n = 35 – 49 per group for WT mice, combining four independent experiments). (b) 
BAL cell counts and (c) BAL total protein determined for uninjured mice and also on day 4 or 7 after LPS-induced injury between Ifng−/− or WT 
mice (n = 9–31 per genotype, combined from 2 or more independent experiments). (d–f) BAL immunophenotyping of CD3+, CD4+, and Tregs in 
uninjured mice and also at days 4 or 7 post LPS administration (n = 9–22 per group, combined from 2 or more independent experiments). (g) Total 
lung cell count obtained from lung digests from uninjured mice or obtained from mice at day 4 or 7 post LPS treatment (n = 9–17 per genotype 
per group, combined data of two independent experiments). (h–k) Changes in macrophage subpopulations and neutrophils as total numbers in 
single-cell suspensions determined by flow cytometry with gating adapted from Misharin et al. (2013). (l–s) Changes in CD3+, CD4+, CD8+, 
Foxp3+, γδ+, CD19+, NK T lymphocyte subsets and NK cells as total numbers in single-cell suspensions determined using a previously published 
lymphocyte flow cytometric panel and gating approach (Mock et al., 2019) (n = 9–17 per group, combined from two independent experiments). 
Data are expressed as the mean ± SEM. p values determined by two-way ANOVA with the Sidak's multiple comparison test. *p < .05, **p < .01 
***p < .001, ****p < .0001
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(Figure 2f). There was no significant difference in the num-
ber of lung Foxp3+ Tregs between genotypes (Figure 2f).
The percentage of effector CD4+ lymphocytes, as deter-
mined by CD44+ CD62Llo surface markers, was lower at day 
6 in Ifng−/− mice (Figure S3c). The percentage of effector 
CD8+ cells was similar in both genotypes. The percentage 
of lung CD4+ lymphocytes that co-expressed Foxp3 did not 
differ between genotypes (Figure S3d).
Similar to the LPS-induced lung injury, the number of 
endothelial cells (CD31+) was higher in Ifng−/− mice com-
pared to WT mice at day 6 post-Sp; however, the number of 
epithelial cells (CD326+) and percent of proliferating endo-
thelial (CD31+) or epithelial (CD326+) cells were similar 
between genotypes (Figure S3e–j). Taken together, IFN-γ 
similarly affects the macrophage subpopulations after Sp and 
LPS-induced ALI, but does not contribute significantly to the 
lymphoid response to Sp.
3.3 | The effects of IFN-γ on immune cell 
kinetics during ALI induced by Influenza A
Mice lacking IFN-γ during influenza-induced (PR8) ALI 
had similar weight loss and recovery compared to control 
mice, which nadired at day 10 post PR8 infection (Figure 
3a). There was no difference in survival between genotypes 
(Figure S4a). The lung histopathology at day 15 demon-
strated similar cellularity between genotypes (Figure S4b). 
The total BAL cell count was similar between genotypes, 
while the BAL total protein concentration was lower in 
Ifng−/− mice (Figure 3b and c, respectively). There was no 
difference in the clearance of PR8 from the lungs (Figure 
S4c).
The lungs of Ifng−/− mice had similar cellularity, as 
demonstrated by the total number of cells obtained in the 
lung digests at 15  days post-PR8 administration (Figure 
F I G U R E  2  Interferon-γ null mice have altered immune cell populations and resolution kinetic parameters after Streptococcus pneumoniae 
ALI. Ifng−/− or WT mice were challenged with intratracheal Streptococcus pneumoniae (Sp) administered on day 0. Mice were examined at day 
6 post-Sp for injury parameters or immunophenotyping in lung digests. (a) Body weight relative to baseline determined after injury (n = 21 for 
Ifng−/− mice; n = 19 for WT mice, combining two independent experiments). (b) BAL cell counts and (c) BAL total protein determined on day 6 
after Sp-induced injury between Ifng−/− or WT mice (n = 16–33 per genotype, combined from two or more independent experiments). (d) Total 
lung cell count obtained from lung digests obtained at day 6 post-Sp treatment exhibit similar cellularity (n = 16–17 per genotype, combined data 
of two independent experiments). (e) Changes in lung macrophage subpopulations and neutrophils as total numbers in single-cell suspensions 
determined by flow cytometry with gating adapted from Misharin et al. (2013). (f) Changes in CD3+, CD4+, CD8+, Foxp3+, γδ+, CD19+, NK T 
lymphocyte subsets and NK cells as total numbers in single-cell suspensions determined using a previously published lymphocyte flow cytometric 
panel and gating approach (Mock et al., 2019). Data are expressed as the mean ± SEM. p values determined by either Mann–Whitney rank sum test 
or one-way ANOVA with the Holm–Sidak, multiple comparison tests. *p < .05, ***p < .001, ****p < .0001
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3d). In these digests, Ifng−/− mice had fewer lung inter-
stitial and inflammatory macrophages and more alveolar 
macrophages at day 15 post PR8 (Figure 3e, Figure S2). 
There were no significant differences at this time point in 
the number of lung CD3+, CD4+, CD8+, CD19+, or γδ+ 
lymphocytes between genotypes (Figure 3f), although PR8 
induced an increase in each of these cell types. However, 
the Ifng−/− lungs contained less NK cells and NK T lym-
phocytes and more Foxp3+ Tregs at day 15 post PR8 
(Figure 3f). The percentage of CD4+ lymphocytes that ex-
pressed Foxp3 was also higher in Ifng−/− than WT mice 
(Figure S4d). In the BAL fluid, comparison of myeloid and 
lymphoid cell numbers revealed that only alveolar, inter-
stitial, and inflammatory macrophages were significantly 
different, and the direction of the changes corresponded to 
those found in the lung digests (data not shown). Taken 
together, IFN-γ similarly affects the macrophage subpopu-
lations during resolution after PR8, Sp, and LPS ALI, and 
contributes more to the lymphoid response following PR8 
than Sp.
The percentage of effector CD8+ lymphocytes was higher 
at day 15 in Ifng−/− mice (Figure S4e). The percentage of 
effector CD4+ cells was similar in both genotypes.
Similar to LPS, PR8 infection resulted in more CD326+ 
epithelial cells in Ifng−/− mice without any change in the 
percentage or number of proliferating epithelial cells (Figure 
S4f–h). The number of endothelial cells was similar between 
genotypes, but the rates and number of proliferating endothe-
lial (CD31+) cells were less in the Ifng−/− mice compared to 
WT mice (Figure S4i–k).
F I G U R E  3  Interferon-γ null mice have altered immune cell populations and resolution kinetic parameters in Influenza-induced ALI. Ifng−/− 
or WT mice were challenged with intratracheal Influenza A/PR/8/34 H1N1 (PR8) administered at day 0. Mice were examined at day 15 post 
PR8-induced for injury parameters or immunophenotyping in lung digests. (a) Body weight relative to baseline determined after injury (n = 26 for 
Ifng−/− mice; n = 31 for WT mice, combining three independent experiments). (b) BAL cell counts and (c) BAL total protein determined on day 15 
after PR8-induced injury between Ifng−/− or WT mice (n = 12–14 per genotype, combined from 2 or more independent experiments). (d) Total lung 
cell count obtained from lung digests obtained at day 15 post PR8 treatment exhibit similar cellularity (n = 12–14 per genotype, combined data of 2 
independent experiments). (e) Changes in lung macrophage subpopulations and neutrophils as total numbers in single-cell suspensions determined 
by flow cytometry with gating adapted from Misharin et al. (2013). (f) Changes in CD3+, CD4+, CD8+, Foxp3+, γδ+, CD19+, NK T lymphocyte 
subsets, or NK cells as total numbers in single-cell suspensions determined using a previously published lymphocyte flow cytometric panel and 
gating approach (Mock et al., 2019). Data are expressed as the mean ± SEM. p values determined by either Mann–Whitney rank sum test or one-
way ANOVA with the Holm–Sidak, multiple comparison tests. *p < .05, **p < .01, ****p < .0001
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3.4 | Neutralizing IFN-γ after initiation of 
ALI affects immune cell populations during 
resolution of ALI
To examine the hypothesis that neutralizing IFN-γ during 
ALI accelerates lung resolution, we performed antibody-
mediated neutralization experiments, in which WT mice 
were given either an IFN-γ neutralizing antibody or an iso-
type antibody control at days 1, 2, and 3 post LPS-induced 
injury. Mice given the IFN-γ neutralizing antibody had sig-
nificantly less weight loss compared to isotype control mice 
(Figure 4a). There was no significant difference in survival 
between antibodies (Figure S5a). Lung histopathology at 
day 4 or 7 post LPS appeared similar between experimental 
groups (Figure S5b and c), as did total BAL cell counts and 
BAL total protein at days 4 and 7 (Figure 4b and c).
WT mice administered anti-IFN-γ antibody had similar 
cellularity, as demonstrated by the total number of cells in 
lung digests at 4 or 7 days (Figure 4d). WT mice given an-
ti-IFN-γ antibody had more alveolar macrophages, similar 
numbers of neutrophils, fewer inflammatory macrophages 
at day 4, and fewer interstitial macrophages at day 7 com-
pared to isotype controls (Figure 4e–h). No significant dif-
ferences were found in the other immune cell populations, 
such as CD3+, CD4+ and CD8+ cells, Foxp3+ Tregs, γδ+ 
lymphocytes, NK T lymphocytes, or NK cells (Figure 4i–p).
The percentages of effector CD4+ and CD8+ lympho-
cytes, as determined by CD44+ CD62Llo surface mark-
ers, were similar between the two groups (Figure S5d–f). 
There were also no differences in the percentage of total 
CD4+ that were Tregs at either time point (Figure S5g). 
Additionally, no differences in the numbers or the per-
cent of proliferating endothelial (CD31+) and epithelial 
(CD326+) cells were measured between genotypes at day 7 
post LPS (Figure S5h–m).
These results suggest that neutralizing IFN-γ impacts on 
some immune cell populations during resolution of LPS-
induced lung injury; however, the neutralizing experiments 
(Figure 4) only partially mirrored the changes seen in ge-
netically deficient mice, even at Day 4 (Figure 1, Figure 
S1).
4 |  DISCUSSION
This report investigates the roles of IFN-γ in ALI in-
duced by three stimuli by examining the effects caused 
by the absence of IFN-γ during these injuries or by neu-
tralizing IFN-γ in one of the stimuli-induced ALI mod-
els. Interestingly, both similarities and differences in the 
functions of IFN-γ were seen when studied using genetic 
depletion or antibody neutralization and are summarized 
graphically in Figures S6 and S7.
Measures of injury showed that peak weight loss after 
LPS was significantly less in the Ifng−/− mice, whereas after 
Sp and PR8, the peak loss and return to baseline were simi-
lar between genotypes. The peak weight loss after LPS was 
also significantly less with IFN-γ neutralization. In the BAL 
supernatant, a lower total protein concentration was observed 
in Ifng−/− mice after Sp and PR8 injuries, but not following 
LPS.
IFN-γ is required for the changes induced by all three 
stimuli in myeloid cells. At the peak of LPS-induced injury 
(day 4 post-injury), IFN-γ is required for full recruitment 
of neutrophils; however, this difference was only observed 
in Ifng−/− mice and not following IFN-γ antibody-medi-
ated neutralization, which was initiated on day 1 after the 
neutrophil influx is established (D'Alessio et al., 2009; 
Zemans & Matthay, 2017). During resolution of all three 
injuries (day 7, 6, or 15), the Ifng−/− mice have more al-
veolar macrophages and fewer interstitial and inflamma-
tory macrophages. These changes also occurred following 
IFN-γ neutralization after LPS-induced injury, except for 
inflammatory macrophages, which are significantly less 
only at day 4 post LPS, likely due to the timing of antibody 
delivery. While there are many mechanisms through which 
these changes in myeloid cells may occur, we postulate that 
IFN-γ may enhance injury, which may result in more de-
struction of alveolar macrophages and greater recruitment 
of inflammatory monocytes/macrophages from the bone 
marrow. One mechanism may be similar to that underlying 
the greater recruitment of inflammatory monocytes and the 
increased lung injury in juvenile compared to adult mice 
following infection with influenza A (Coates et al., 2018). 
These authors provide evidence that a sustained type I IFN 
response in juvenile mice leads to continued expression of 
CCL2 (MCP-1), more inflammatory monocytes entering 
the lungs, prolonged expression of cytokines, and enhanced 
and prolonged lung injury in the juvenile mice (Coates et 
al., 2018). In our studies, the lack of IFN-γ likely contrib-
utes to less CCL2 and less recruitment of inflammatory 
macrophages, but other effects of IFN-γ may mediate other 
aspects of the Ifng−/− mouse phenotype.
In contrast, the contributions IFN-γ makes to lymphoid 
cell numbers depends on the stimulus. During resolution of 
LPS-induced lung injury, IFN-γ is also required for a full re-
sponse of lymphocytes, including CD3+, CD4+, CD8+, and 
γδ+, and NK cells. In Sp-induced injury, Ifng−/− mice have 
higher numbers of γδ+ lymphocytes and fewer NK cells than 
WT mice. PR8 induces the highest numbers of CD3+ lym-
phocytes during resolution; however, the absence of IFN-γ 
does not change the numbers of CD3+, CD4+, or CD8+ lym-
phocytes. NK T lymphocyte and NK cell numbers are lower 
in Ifng−/− compared to WT mice after PR8.
Interestingly, antibody neutralization at 1, 2, and 3  days 
post LPS induced an increase in CD19+ B cells at day 4, 
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F I G U R E  4  Interferon-γ neutralization augments ALI recovery. WT mice were challenged with LPS administered at day 0 and then on 
days 1, 2, and 3 post LPS mice were given intraperitoneal injections of 20 μg/mouse of either an IFN-γ neutralizing antibody or isotype control 
antibody. Mice were weighed daily and examined at day 4 or 7 post LPS for injury parameters or immunophenotyping in the BAL compartment 
or lung digests (n = 8–17 per group, combined from at least two independent experiments) (a) Body weight relative to baseline determined after 
injury. (b) BAL cell counts numbers total protein concentration, (c) BAL total protein concentration, and (d) Total lung cell counts obtained from 
enzymatically digested single-cell suspension are similar between antibody administrations. (e–h) Changes in lung macrophage subpopulations 
and neutrophils as total numbers in single-cell suspensions determined by flow cytometry with gating adapted from Misharin et al. (2013). (i–p) 
Changes in CD3+, CD4+, CD8+, Foxp3+, γδ+, CD19+, NK T lymphocytes subsets and NK cells as total numbers in single-cell suspensions 
determined using a previously published lymphocyte flow cytometric panel and gating approach (Mock et al., 2019). p values determined by two-
way ANOVA with the Holm–Sidak multiple comparison tests. *p < .05, **p < .01 ***p < .001, ****p < .0001
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whereas the Ifng−/− mice had no effect (Figure S7). Since the 
control antibody appeared to decrease CD19+ cells (Figure 1q 
compared to 4n), an antibody-mediated nonspecific could con-
tribute to this finding. Lastly, the neutralization experiments 
did not affect the percentage of effector CD4+ or CD8+ cells. 
Collectively, antibody neutralization of IFN-γ elicits a smaller 
number of effects compared to the genetic depletion of Ifng 
after LPS-induced injury. This may be due to the delay in anti-
body administration until 24 hr after initiation of injury, a par-
tial neutralization of IFN-γ activity, or IFN-γ autocrine or local 
paracrine effects that may not be neutralized by the antibody.
We and others have demonstrated that Tregs play an es-
sential role in the resolution of ALI (D'Alessio et al., 2009; 
Dial et al., 2017; Lin, Wu, Wang, Xiao, & Xu, 2018; Mock et 
al., 2014). Following LPS injury, Tregs are increased on day 
7 in WT mice (Mock et al., 2019). Despite the fact that Tregs 
can regulate the expression of IFN-γ and that IFN-γ can regu-
late Treg functions (Overacre-Delgoffe et al., 2017; Panduro, 
Benoist, & Mathis, 2018; Sojka & Fowell, 2011), IFN-γ does 
not affect the numbers of Tregs after LPS or S. pneumoniae. 
In contrast, IFN-γ negatively regulates the increase in Tregs 
induced by influenza. These data suggest that Treg prolifera-
tion, recruitment from other sites, or extra-thymic peripheral 
expression of Foxp3 during influenza infection may be nega-
tively regulated by IFN-γ (Olalekan, Cao, Hamel, & Finnegan, 
2015). The fact that Ifng−/− mice still retain some ability to 
increase the numbers of Tregs during influenza, as well as fol-
lowing LPS and Sp injuries, suggests that there are also IFN-
γ-independent mechanisms for enhancing Treg numbers.
Surprisingly, the total number of epithelial (CD326+) and 
endothelial (CD31+) cells were increased in number 7 days 
post LPS in Ifng−/− mice. One possibility is that IFN-γ en-
hances the injury- and/or immune-mediated destruction of 
epithelial and endothelial cells after LPS injury. Another pos-
sibility is that IFN-γ blunts the pace of endothelial and/or ep-
ithelial repair after injury. The data demonstrating earlier or 
accelerated endothelial proliferation kinetics in Ifng−/− mice 
after LPS support this hypothesis. In the Sp-induced injury, 
Ifng−/− mice demonstrated increased numbers of endothelial 
cells during resolution, whereas after PR8-induced injury, the 
Ifng−/− mice had higher numbers of epithelial cells compared 
to WT controls. Importantly, the differences in isolation con-
ditions or in endothelial or epithelial cell viability between 
genotypes may complicate the differences measured in these 
cell types and should be considered.
Overall, IFN-γ enhances injury and may delay recovery, 
as measured by return to pre-injury weight, BAL protein lev-
els, and clearance of inflammatory cells. The mechanisms 
by which IFN-γ coordinates its impact upon ALI resolution 
are likely multifactorial. First, IFN-γ may act by directly sig-
naling immune cell populations, through the production of 
downstream chemokines, cytokines, and their mediators, or by 
inducing apoptosis (Schroder et al., 2004). IFN-γ may target 
multiple cell types, including alveolar macrophages. Second, in 
contrast to the myeloid cell kinetics, which are similar for the 
three different stimuli, the differences in lymphoid responses 
between ALI stimuli likely underline injury-specific require-
ments for the recruitment of lymphocytes. However, we cannot 
exclude the possibility that the differences in the roles of IFN-γ 
between injuries are due to the time points examined, which 
may not represent an identical point in the resolution process.
Comparing and contrasting the results of genetic deletion 
or antibody neutralization suggests that temporal regulation 
of IFN-γ during injury is a crucial factor in IFN-γ’s functions. 
The lack of IFN-γ activity early during injury (within the first 
24 hr) is essential in impacting neutrophil recruitment at Day 
4. Administering antibody neutralization at days 1, 2, and 3 
does not affect neutrophil numbers at Day 4, but exerts an ef-
fect similar to genetic deletion on alveolar macrophages and 
inflammatory macrophages.
Our data support and expand the work of others who have 
suggested that dampening the function of IFN-γ may be bene-
ficial in ALI. One prospective observational cohort study per-
formed a cluster analysis of 20 potential biomarkers in plasma 
of ARDS patients and found different ARDS phenotypes 
(Bos et al., 2017). This study identified a set of four biomark-
ers, Angiopoietin 1/2, IFN-γ, IL-6, and plasminogen activator 
inhibitor 1, which could categorize two phenotypic groups of 
ARDS patients. The “reactive” phenotype group, which had 
higher levels of these four mediators, including IFN-γ, had 
significantly higher mortality than the “uninflamed” pheno-
type (Bos et al., 2017). The authors of this study suggested 
that this “reactive” ARDS phenotype may benefit from tar-
geted pharmacological interventions (Bos et al., 2017). Other 
work also supports CD8+ cells as contributing to IFN-γ pro-
duction and lung injury (Ramana et al., 2015; Wlodarczyk et 
al., 2013). These studies, along with ours, demonstrate that 
potential immunotherapy to block or neutralize IFN-γ could 
be useful in controlling severe lung inflammation. Recently, 
in the United States, a recombinant IFN-γ blocking antibody 
(Emapalumab) was approved for patients with primary he-
mophagocytic lymphohistiocytosis (Al-Salama, 2019).
In summary, our results illustrate the complexity of lung 
injury and its resolution and provide insight into the effects of 
one cytokine on lung injury and resolution. Uncoupling IFN-
γ’s effect on peak injury from its effect on resolution remains 
an incomplete task. Understanding the interactions between 
inflammation and repair is critical to identify approaches that 
minimize tissue damage without adversely altering the host 
response.
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